Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Recommendation of “Buy” by Brokerages

Mobia Medical, Inc. (NASDAQ:MOBI) has been assigned a consensus rating of “Buy” from the five research firms that are covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $20.25.

A number of equities research analysts have commented on the company. Bank of America assumed coverage on Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $16.00 price target on the stock. Wall Street Zen raised Mobia Medical to a “hold” rating in a research note on Saturday, May 16th. The Goldman Sachs Group assumed coverage on Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $31.00 target price on the stock. JPMorgan Chase & Co. assumed coverage on shares of Mobia Medical in a research report on Tuesday. They set an “overweight” rating and a $15.00 target price for the company. Finally, BTIG Research began coverage on shares of Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $19.00 price target on the stock.

Insider Buying and Selling at Mobia Medical

In other Mobia Medical news, major shareholder Osage University Gp Iii, Llc purchased 533,333 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was purchased at an average cost of $15.00 per share, for a total transaction of $7,999,995.00. Following the acquisition, the insider owned 2,006,716 shares in the company, valued at approximately $30,100,740. The trade was a 36.20% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Dana G. Jr. Mead acquired 7,000 shares of the stock in a transaction dated Monday, May 11th. The stock was acquired at an average cost of $15.00 per share, with a total value of $105,000.00. Following the completion of the transaction, the director owned 7,000 shares in the company, valued at approximately $105,000. This represents a ? increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 1,268,332 shares of company stock valued at $19,024,980 over the last three months.

Mobia Medical Stock Up 3.1%

NASDAQ MOBI traded up $0.40 on Tuesday, reaching $13.50. The company had a trading volume of 108,517 shares, compared to its average volume of 105,848. The company has a market capitalization of $446.65 million, a price-to-earnings ratio of 66.00 and a beta of 2.84. Mobia Medical has a fifty-two week low of $10.19 and a fifty-two week high of $14.04.